Ipilimumab vs Levofloxacin
Ipilimumab vs Levofloxacin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Levofloxacin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days; Levofloxacin — 6-8 hours.
Chemical Properties
Molecular Formula: Levofloxacin — C18H20FN3O4.
Molecular Weight: Levofloxacin — 361.3680 g/mol.
Type: Ipilimumab — Antibody; Levofloxacin — Small molecule.